Heavy chain subclass of human anti-platelet antibodies.
D000818:Animals; D000906:Antibodies / Q000032:analysis* / Q000145:classification; D000918:Antibody Specificity; D000941:Antigens; D001327:Autoimmune Diseases / Q000276:immunology; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000276:immunology*; D001803:Blood Transfusion; D002220:Carbamazepine / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000276:immunology; D000882:Haplorhini / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D007128:Immunoglobulin Fragments / Q000032:analysis*; D007074:Immunoglobulin G / Q000145:classification; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D009194:Myeloma Proteins; D010743:Phospholipids / Q000032:analysis; D011696:Purpura, Thrombocytopenic / Q000276:immunology; D011802:Quinidine / Q000009:adverse effects; D011817:Rabbits / Q000276:immunology; D013866:Thioguanine / Q000009:adverse effects
D000906:Antibodies; D000941:Antigens; D001779:Blood Coagulation Factors; D007106:Immune Sera; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G; D009194:Myeloma Proteins; D010743:Phospholipids; D002220:Carbamazepine; D013866:Thioguanine; D011802:Quinidine